William Aliski Insider Trading $RARE Ultragenyx Pharmaceutical Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for William Aliski.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of William Aliski. William Aliski is Director in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and Director in X4 Pharmaceuticals, Inc ($ASNS) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE).

William Aliski in Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Aliski: Director
Holdings: 73,204 shares
Current Value: $5,337,304
Latest Transaction: Feb 23 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of William Aliski in Ultragenyx Pharmaceutical Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGTC, RARE, ASNS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2021RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseM97.857,500733,8750
Feb 23 2021RAREUltragenyx Pharmac ...Aliski WilliamDirectorGiftG0.001,000064,70465.7 K to 64.7 K (-1.52 %)
Feb 23 2021RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS149.017,5001,117,57565,70473.2 K to 65.7 K (-10.25 %)
Feb 23 2021RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyM97.857,500733,87573,20465.7 K to 73.2 K (+11.41 %)
Aug 25 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseM58.745,000293,7000
Aug 25 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS86.575,000432,85057,01862 K to 57 K (-8.06 %)
Aug 25 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyM58.745,000293,70062,01857 K to 62 K (+8.77 %)
Jun 30 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA76.584,250325,4654,250
Jun 30 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorGrantA0.002,550057,01854.5 K to 57 K (+4.68 %)
Jun 03 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS74.0220,0001,480,32270,35090.4 K to 70.4 K (-22.14 %)
May 20 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseM40.377,500302,7750
May 20 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS74.657,500559,87547,92455.4 K to 47.9 K (-13.53 %)
May 20 2020RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyM40.377,500302,77555,42447.9 K to 55.4 K (+15.65 %)
Jun 13 2019RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA58.745,000293,7005,000
Jun 13 2019RAREUltragenyx Pharmac ...Aliski WilliamDirectorGrantA0.003,000047,92444.9 K to 47.9 K (+6.68 %)
Dec 07 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS49.696,000298,14090,35096.4 K to 90.4 K (-6.23 %)
Nov 08 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS55.676,000334,02096,350102.4 K to 96.4 K (-5.86 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseC0.00266,34300
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS73.386,000440,280102,350108.4 K to 102.4 K (-5.54 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS53.9765035,081108,350109 K to 108.4 K (-0.60 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS122.5840049,032109,000109.4 K to 109 K (-0.37 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS85.942,000171,880109,400111.4 K to 109.4 K (-1.80 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS68.6510,500720,825111,400121.9 K to 111.4 K (-8.61 %)
Oct 09 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyC0.0084,9700121,90036.9 K to 121.9 K (+230.08 %)
Aug 08 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS76.663,750287,47572,61076.4 K to 72.6 K (-4.91 %)
Jun 20 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA80.695,000403,4505,000
Jun 20 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorGrantA0.003,000076,36073.4 K to 76.4 K (+4.09 %)
Jan 25 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseM21.0011,500241,5000
Jan 25 2018RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyM21.0011,500241,50073,36061.9 K to 73.4 K (+18.59 %)
Jun 22 2017RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA65.663,750246,2253,750
Jun 22 2017RAREUltragenyx Pharmac ...Aliski WilliamDirectorGrantA0.001,875061,86060 K to 61.9 K (+3.13 %)
Dec 05 2016RAREUltragenyx Pharmac ...Aliski WilliamOption ExerciseM21.006,000126,00011,500
Dec 05 2016RAREUltragenyx Pharmac ...Aliski WilliamSellS78.702,000157,40059,98562 K to 60 K (-3.23 %)
Dec 05 2016RAREUltragenyx Pharmac ...Aliski WilliamSellS77.944,000311,76061,98566 K to 62 K (-6.06 %)
Dec 05 2016RAREUltragenyx Pharmac ...Aliski WilliamBuyM21.006,000126,00065,98560 K to 66 K (+10.00 %)
Jun 14 2016RAREUltragenyx Pharmac ...Aliski WilliamOption ExerciseA65.853,750246,9383,750
Jun 14 2016RAREUltragenyx Pharmac ...Aliski WilliamGrantA0.001,875059,98558.1 K to 60 K (+3.23 %)
Jun 22 2015RAREUltragenyx Pharmac ...Aliski WilliamOption ExerciseA97.857,500733,8757,500
Dec 08 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS42.463,109132,01360,01063.1 K to 60 K (-4.93 %)
Dec 08 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorSellS41.832,891120,92963,11966 K to 63.1 K (-4.38 %)
Oct 22 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseM3.0129,10887,6150
Oct 22 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyM3.0129,10887,61566,01036.9 K to 66 K (+78.88 %)
Jul 17 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA40.377,500302,7757,500
Feb 07 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseJ3.0129,10887,6150
Feb 07 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseJ0.9691,24187,5000
Feb 03 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorOption ExerciseA21.0017,500367,50017,500
Feb 03 2014RAREUltragenyx Pharmac ...Aliski WilliamDirectorBuyP21.005,000105,00036,90331.9 K to 36.9 K (+15.67 %)

Page:   1